NDA provides unmatched regulatory expertise, partnering with our clients to ensure the optimal development of complex and innovative treatments to meet the rigorous requirements of the regulatory agencies.
Over the last 3 years, we have supported a quarter of the new medicinal products approved in the US and Europe.
More About Us
NDA’s sole commitment is to make sure that the best possible medicines reach the market without unnecessary delay and ensuring that they remain there for as long as they benefit the patients.
Our leadership Team
The executive team at NDA has the privilege of leading an organization of unmatched experience in the drug development disciplines. With backgrounds from entrepreneurship, large and small research organisations and the regulatory agencies they work together to continually grow NDA and expand our capabilities in line with the evolving needs of our industry.
NDA Advisory Board
The NDA Advisory Board brings together some of the most prominent experts in regulatory affairs, pharmacovigilance and HTA. All are ex-regulators or senior industry leaders, renown for the contribution they have made to drug development throughout their careers.
Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance, health technology assessment and scientific communications on a variety of projects, clients and geographies.
NDA USA New Jersey
NDA Group AB
S-194 61 Upplands Väsby
Neumarkter Straße 18
Surrey KT22 9DF
NDA USA NEW JERSEY
200 Princeton South Corporate Center,
Ewing, NJ 08628